SRP-1003

RNA / oligonucleotide

Earlyevidence

Evidence outlook

Early-stage evidence only

Phase 1 / first-in-human studies establish safety, tolerability, and dosing; they are not designed to demonstrate efficacy, so no evidence signal is assigned yet. The first graded signal arrives with a completed confirmatory readout.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 1/2 (1)
Other / comorbidity

Competitive landscape

This drug's own stage for Myotonic Dystrophy Type 1: Stage not on record. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
SRP-1003: this drugStage not on recordRNA / oligonucleotideDMPK (dystrophia myotonica protein kinase)not yet gradedNo reviewed efficacy summary in this indication
Delpacibart EtedesiranPhase 3RNA / oligonucleotideDMPKnot yet gradedNo reviewed efficacy summary in this indication
Pitolisant (Wakix)Phase 2Small moleculeHistamine H3 receptor (antagonist / inverse agonist)not yet gradedNo reviewed efficacy summary in this indication
VX-670Phase 2RNA / oligonucleotideDMPK CUG-repeat RNAnot yet gradedNo reviewed efficacy summary in this indication
SAR446268Phase 1/2Gene therapy / editingDMPKnot yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(1 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow SRP-1003 to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2026 (1)
December 2026 (1)
Phase 1/2Myotonic Dystrophy 1Enrolling by invitation
Est. primary completion 2026-12-31 · NCT06138743 · CT.gov ↗
What to watch

See the full readout calendar ↗